Amenorrhea pp 187-201 | Cite as

Long-Term Implications of Oophorectomy at the Time of Hysterectomy for Benign Disease

  • Donna Shoupe
  • Jonathan S. BerekEmail author
Part of the Contemporary Endocrinology book series (COE)


The National Center for Health Statistics report that in 2004, of the 617,000 ­hysterectomies performed in the USA, 73% also involved the surgical removal of the ovaries. In the United States, by age 60, about 1/3 of women undergo a hysterectomy [1, 2]. Over the past decade, an average of 622,000 hysterectomies per year have been performed, and it is now estimated that there are 22 million women in the USA who have undergone this procedure [2]. According to the CDC, 52% of all hysterectomies are performed in women aged 44 years of age or younger. Of over 3 million hysterectomies performed between 1994 and 1999 in the USA, slightly over 10% were done for a primary diagnosis of cancer (Table 11.1). It is important to recognize the long-term implications of hysterectomy with and without oophorectomy and to counsel patients accordingly.


Ovarian Cancer Coronary Artery Calcium Bilateral Oophorectomy Natural Menopause Early Menopause 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Wu JM, Wechter ME, Geller EJ et al (2007) Hysterectomy rates in the United States, 2003. Obstet Gynecol 110:1091PubMedCrossRefGoogle Scholar
  2. 2.
    Hysterectomy. National women’s Health Information center (2006-07-01). Accessed 4 Oct 2009
  3. 3.
    Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D (1994) Rates and risks of ovarian cancer in subgroups of white women in the United States. The Collaborative Ovarian Cancer Group. Obstet Gynecol 84(5):760–764PubMedGoogle Scholar
  4. 4.
    Dekel A, Efrat Z, Orvieto R, Levy T, Dicker D, Gal R, Ben-Rafael Z (1996) The residual ovary syndrome: a 20 year experience. Eur J Obstet Gynecol Reprod Biol 68(1–2):159–164PubMedCrossRefGoogle Scholar
  5. 5.
    Holub Z, Jandourek M, Jabor A, Kliment L, Wagnerova M (2000) Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study. Clin Exp Obstet Gynecol 27(2):109–112PubMedGoogle Scholar
  6. 6.
    Christ JE, Lotze EC (1975) The residual ovary syndrome. Obstet Gynecol 46(5):551–556PubMedGoogle Scholar
  7. 7.
    Colditz CA, Willett W, Stampfer M, Rosner B, Speizer F, Hennekens C (1987) Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105–1110PubMedCrossRefGoogle Scholar
  8. 8.
    Atsma F, Bartelink M, Grobbee D, van der Schouw Y (2006) Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis. Menopause 13(2):265–279PubMedCrossRefGoogle Scholar
  9. 9.
    Parker WH, Broder M, Liu Z, Shoupe D, Farquhar C, Berek J (2005) Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219PubMedCrossRefGoogle Scholar
  10. 10.
    Rocca W, Grossardt BR, de Andrade M, Jalkasian GD, Melton LJ III (2006) Survival patterns after oophorectomy in premenopausal women: a population based cohort study. Lancet Oncol 7(10):821–828PubMedCrossRefGoogle Scholar
  11. 11.
    Parker WH, Broder MS, Change E, Feskanich D, Farquhar C, Shoupe D, Berek J, Hankinson S, Mason JE (2009) Ovarian conservation and long-term health outcome in the Nurses’ Health Study. Obstet Gynecol 113(5):1027–1037PubMedGoogle Scholar
  12. 12.
    Farquhar CM, Sadler L, Harvey SA, Stewart AW (2005) The association of hysterectomy and menopause: a prospective cohort study. BJOG 112(7):956–962PubMedCrossRefGoogle Scholar
  13. 13.
    Menon RK, Okonofua FE, Agnew JE et al (1987) Endocrine and metabolic effects of simple hysterectomy. Int J Gynaecol Obstet 25(6):459–463PubMedCrossRefGoogle Scholar
  14. 14.
    Laughlin GA, Barrett-Connor E, Kritz-Silverstein D, von Muhlen D (2000) Hysterectomy, oophorectomy, and endogenous sex hormone levels in older women: the Rancho Bernardo study. J Clin Endocrinol Metab 85(2):645–651PubMedCrossRefGoogle Scholar
  15. 15.
    Nahas E, Pontes A, Traiman P, NahasNeto J, Dalben I, DeLuca L (2003) Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age. Gynecol Endocrinol 17:125–131PubMedGoogle Scholar
  16. 16.
    Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M (1988) Effects of natural menopause, hysterectomy, and oophorectomy on lumbar spine and femoral neck bone densities. Obstet Gynecol 72(4):631–638PubMedGoogle Scholar
  17. 17.
    Watson NR, Studd JW, Garnett T, Savvas M, Milligan P (1995) Bone loss after hysterectomy with ovarian conservation. Obstet Gynecol 86(1):72–77PubMedCrossRefGoogle Scholar
  18. 18.
    Nieman LK (2003) Management of surgically hypogonadal patients unable to take hormone replacement. Endocrinol Metab 32:325–336Google Scholar
  19. 19.
    Thompson B, Hart SA, Durno D (1973) Menopausal age and symptomatology in a general practice. J Biosoc Sci 5:71–82PubMedCrossRefGoogle Scholar
  20. 20.
    Madalinska JB, van Beurden M, Bleiker EM et al (2006) The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy. J Clin Oncol 24(22):3519–3521CrossRefGoogle Scholar
  21. 21.
    Gallicchia L, Whiteman MK, Tomic D, Miller KP, Lanagerberg P, Flaws JA (2006) Type of menopause, pattern of hormone use, and hot flashes. Fertil Steril 95(5):1432–1440CrossRefGoogle Scholar
  22. 22.
    Melville JL, Katon W, Delaney K, Newton K (2005) Urinary incontinence in US women: a population based study. Arch Intern Med 165(5):537–542PubMedCrossRefGoogle Scholar
  23. 23.
    Roos NP (1984) Hysterectomies in one Canadian province: a new look at risks and benefits. Am J Public Health 74:39–46PubMedCrossRefGoogle Scholar
  24. 24.
    Sherwin BB, Gelfan MM (1978) The role of androgens in the maintenance of sexual functioning in oophorectomized women. Psychosom Med 49:397–409Google Scholar
  25. 25.
    Nathorst-Boos J, von Schoultz B, Carlstrom K (1993) Elective ovarian removal and estrogen replacement therapy-effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol 14(4):283–293PubMedCrossRefGoogle Scholar
  26. 26.
    Hansen KA (2007) Female reproductive biology. In: O’Leary P, Tabuenca A, Capote LR (eds) The physiologic basis of surgery. Lippincott Williams and Wilkins, Hagerstown, MD, pp 314–315Google Scholar
  27. 27.
    Bachman GA, Nevadunsky NS (2000) Diagnosis and treatment of atrophic vaginitis. Am Fam Physician 61:3090–3096Google Scholar
  28. 28.
    Lieblum S, Bachmann G, Kemmann E, Colburn D, Swartzman L (1983) Vaginal atrophy in the postmenopausal woman. The importance of sexual activity and hormones. JAMA 249:2195–2198CrossRefGoogle Scholar
  29. 29.
    Schifren JL, Braustein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA (2000) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343(10):682–688CrossRefGoogle Scholar
  30. 30.
    Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmone GP, Burki RE, Gkinsburg ES, Rosen RC, Leiblum SR, Carameli KE, Mazer NA (2001) Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. Obstet Gynecol Surv 56(2):95–96CrossRefGoogle Scholar
  31. 31.
    Elit I, Esplen MJ, Butler K, Narod S (2001) Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Fam Cancer 1(3–4):149–156PubMedCrossRefGoogle Scholar
  32. 32.
    Madalinska JB, Hollenstein J, Bleiker E, van Beurden M, Valdimarsdottir HB, Massuger LF, Gaarenstroom KN, Mouritis JM, Verheijen RH et al (2005) Quality of life effects of prophylactic salpingo-oophorectomy versus gnecolgic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23(29):2690–2698Google Scholar
  33. 33.
    Sherwin BB (1988) Affective changes with estrogen and androgen replacement in surgically menopausal women. J Affect Disord 14(2):177–178PubMedCrossRefGoogle Scholar
  34. 34.
    Farrag AK, Khedr EM, Abdel-Aleem H, Rageh TA (2002) Effect of surgical menopause on cognitive functions. Dement Geriatr Cogn Disord 13(3):193–198PubMedCrossRefGoogle Scholar
  35. 35.
    Nilsen J, Chen S, Irwin RW, Iwamoto S, Brinton RD (2006) Estrogen protects neuronal cells form amyloid beta-induced apoptosis via regulation of mitochondrial proteins and function. BMC Neurosci 3:7–74Google Scholar
  36. 36.
    Rocca WA, Bower JH, Maraganore DM, Ahiskog JE, Grossartdt BR, DeAndrade M, Melton LH (2007) Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 69(11):1074–1083PubMedCrossRefGoogle Scholar
  37. 37.
    Rocca W, Grossardt BR, Maraganore DM (2008) The long-term effects of oophorectomy on cognitive and motor aging are age dependent. Neurodegener Dis 5:257–260PubMedCrossRefGoogle Scholar
  38. 38.
    Halbreich U, Lumley LA, Palter S et al (1995) Possible acceleration of age effects on cognition following menopause. J Psychiatr Res 29:153–163PubMedCrossRefGoogle Scholar
  39. 39.
    Dennerstein L, Guthrie JF, Clark M, Lehert P, Henderson VW (2004) A population-based study of depressed mood in middle aged Australian-born women. Menopause 11:563–568PubMedCrossRefGoogle Scholar
  40. 40.
    McKinlay JB, McKinlay SM, Brambilla DJ (1987) The relative contribution of endocrine changes and social circumstances to depression in middle aged women. J Health Soc Behav 28(4):345–363PubMedCrossRefGoogle Scholar
  41. 41.
    Billon A, Lehoux S, Shang Leen LL et al (2008) The estrogen effects on endothelial repair. Am J Pathol 172:830–838PubMedCrossRefGoogle Scholar
  42. 42.
    Behl C, Skutella T, Lezoualc’H F, Post A, Widmann M, Newton CJ, Holsboer F (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 51:535–541PubMedGoogle Scholar
  43. 43.
    Raisz RK, Wilta B, Artis A, Bowen A, Schwartz S, Trahiotis M, Shoukri K, Smith J (1996) Comparison of the effects of estrogen alone and estrogen plus androgen on biochemical markers of bone formation and resorption in postmenopausal women. J Clin Endocrinol Metab 81(1):37–43PubMedCrossRefGoogle Scholar
  44. 44.
    National Osteoporosis Foundation (1998) Physician guide to prevention and treatment of osteoporosis. Excerpta Medica, Belle Mead, NJGoogle Scholar
  45. 45.
    Vermeulen A (1976) The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 42:247–253PubMedCrossRefGoogle Scholar
  46. 46.
    Fogle R, Stanczyk F, Zhang X, Paulson R (2007) Ovarian androgen production and the postmenopausal ovary. J Clin Endocrinol Metab 92:3040–3043PubMedCrossRefGoogle Scholar
  47. 47.
    Davidson SL, Bell R, Donath S, Montalto JF, Davis SR (2005) Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 90(7):3847–3853CrossRefGoogle Scholar
  48. 48.
    Davidson BJ, Ross RK, Paganini-Hill A, Hammond GD, Siiteri PK, Judd HL (1982) Total and free estrogens and androgens in postmenopausal women with hip fractures. J Clin Endocrinol Metab 54(1):115–120PubMedCrossRefGoogle Scholar
  49. 49.
    Longcope C, Baker RS, Hui SL, Johnston CC Jr (1984) Androgen and estrogen dynamics in women with vertebral crush fractures. Maturitas 6(4):309–318PubMedCrossRefGoogle Scholar
  50. 50.
    Kreiger N, Kelsey J, Holford TR, O’Connor T (1982) An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol 116(1):141–148PubMedGoogle Scholar
  51. 51.
    Ohtaa H, Makitab K, Komukaib S, Nozawab S (2002) Bone resorption versus estrogen loss following oophorectomy and menopause. Maturitas 43(1):27–33CrossRefGoogle Scholar
  52. 52.
    Johansson C, Mellstrom D, Milsom I (1993) Reproductive factors as predictors of bone density and fracture in women at the age of 70. Maturitas 17(1):39–50PubMedCrossRefGoogle Scholar
  53. 53.
    Keene G, Parker M, Pryor G (1993) Mortality and morbidity after hip fractures. BJM 13:1248–1250CrossRefGoogle Scholar
  54. 54.
    Center J, Nguyen T, Schneider D, Sambrook P, Eisman J (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878–882PubMedCrossRefGoogle Scholar
  55. 55.
    Vingerling JR, Dielemans I, Witteman CM et al (1994) Macular degeneration and early menopause: a case-control study. Br Med J 310:1570CrossRefGoogle Scholar
  56. 56.
    Worzala K, Hiller R, Sperduto RD, Mutalik K, Murabito JM, Moskowitz M, D’Agostino RB, Wilson PWF (2001) Postmenopausal estrogen use, type of menopause, and lens opacities. The Framingham Studies. Arch Intern Med 161:1448–1454PubMedCrossRefGoogle Scholar
  57. 57.
    Floter A, Nathorst-Boos J, Carlstrom K, Ohlsson C, Ringertz H, Schoultz B (2005) Effects of combined estrogen/testosterone therapy on bone and body composition in oophorectomized women. Gynecol Endocrinol 20(3):155–160PubMedCrossRefGoogle Scholar
  58. 58.
    Brincat M, Moniz CJ, Studd JW, Darby A, Magos A, Emburey G, Versi E (1985) Long-term effects of the menopause and sex hormones on skin thickness. Br J Obstet Gynaecol 92(3):256–259PubMedCrossRefGoogle Scholar
  59. 59.
    Brincat M, Kabalan S, Studd JW, Moniz CF, de Trafford J, Montgomery J (1987) A study of the decrease in skin collagen content, skin thickness, and bone mass in the postmenopausal woman. Obstet Gynecol 70(6):840–849PubMedGoogle Scholar
  60. 60.
    Donato GB, Fuchs SC, Oppermann K, Bastos C, Spritzer PM (2006) Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause 13(2):280–285PubMedCrossRefGoogle Scholar
  61. 61.
    Haarbo J, Marslew U, Gotfredsen A, Christiansen C (1991) Postmenopausal hormone replacement prevents central distribution of body fat after menopause. Metabolism 40(12):1322–1326CrossRefGoogle Scholar
  62. 62.
    Falkeborn M, Schairer C, Naessen T, Persson I (2000) Risk of myocardial infarction after oophorectomy and hysterectomy. J Clin Epidemiol 53:832–837PubMedCrossRefGoogle Scholar
  63. 63.
    Rosenberg L, Hennekens CH, Rosner B, Belanger C, Rothman KJ, Speizer FE (1981) Early menopause and the risk of myocardial infarction. Am J Obstet Gynecol 139:47–51PubMedGoogle Scholar
  64. 64.
    Kanel WB, Hjortland MC, McNamara PM, Gordon T (1976) Menopause and risk of cardiovascular disease. The Framingham Study. Ann Intern Med 85:447–452Google Scholar
  65. 65.
    Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR (1989) Menopause and risk factors for coronary heart disease. N Engl J Med 321(10):641–652PubMedCrossRefGoogle Scholar
  66. 66.
    Wuerst J, Dry T, Edwards J (1953) The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation 7:891–899Google Scholar
  67. 67.
    Hsia J, Barad D, Margolis K, Rodabough R, McGovern P, Limacher M et al (2003) Usefulness of prior hysterectomy as an independent risk predictor of Framingham risk score. Am J Cardiol 92:264–269PubMedCrossRefGoogle Scholar
  68. 68.
    Robinson RW, Higano N, Cohen WD (1959) Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch Intern Med 104:908–913PubMedCrossRefGoogle Scholar
  69. 69.
    Van der Schouw Y, van der Fraaf Y, Steyerberg E, Elijkemans M, Banga J (1996) Age at menopause as a risk factor for cardiovascular mortality. Lancet 347:714–718PubMedCrossRefGoogle Scholar
  70. 70.
    Lokkegaard E, Jovanovic Z, Heitmann BL, Keidling N, Ottesen B, Pedersen AT (2006) The association between early menopause and risk of ischemic heart disease: influence of hormone therapy. Maturitas 53(2):226–233PubMedCrossRefGoogle Scholar
  71. 71.
    Hu FB, Grodstein F, Hennekens CH, Colditz GA, Hohnson M, Manson JE, Rosner B, Stampfer MJ (1999) Age at natural menopause and risk of cardiovascular disease. Arch Intern Med 159:1061–1066PubMedCrossRefGoogle Scholar
  72. 72.
    Cheung LP, Pang MW, Lam CW, Tomlinson B, Chung TK, Haines CJ (1998) Acute effects of a surgical menopause on serum concentrations of lipoprotein(a). Climacteric 1(1):33–41PubMedCrossRefGoogle Scholar
  73. 73.
    Suda Y, Makita KI, Takamatsu K, Horiguchi F, Nozawa S (1998) Influence of bilateral oophorectomy upon lipid metabolism. Maturitas 29:147–154PubMedCrossRefGoogle Scholar
  74. 74.
    Mihmanli V, Mihmanli I, Kantarci F, Aydin T, Yilmaz MH, Ogut G (2002) Carotid pulsatility indices in surgical menopause. Arch Gynecol Obstet 266(2):96–100PubMedCrossRefGoogle Scholar
  75. 75.
    Mollica G (1993) Influence of spontaneous and surgical menopause on atherogenic metabolic risk. Maturitas 17(3):181–190PubMedCrossRefGoogle Scholar
  76. 76.
    Schulman JH, Aranda P, Roij L, Veronesi M, Aranda FJ, Martin R (2006) Surgical menopause increases salt sensitivity for blood pressure. Hypertension 47(6):1168–1174PubMedCrossRefGoogle Scholar
  77. 77.
    DeLeo V, La Marca A, Agricol E, Morgante G, Mondillo S, Setacci C (2002) Resting ECG is modified after oophorectomy and regresses with estrogen replacement therapy in premenopausal women. Maturitas 31(1):43–47Google Scholar
  78. 78.
    Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN (2004) Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause. Fertil Steril 82(2):391–397PubMedCrossRefGoogle Scholar
  79. 79.
    Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P, Hendrix S, Hsia J, Hunt JR, Jackson RD, Johnson KC, Kuller LH, Robinson J; Women’s Health Initiative and Women’s Health Initiative Coronary Artery calcium study investigators (2008) Oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: The Women’s Health Initiative Coronary Artery Calcium Study. Menopause 15:639–647CrossRefGoogle Scholar
  80. 80.
    Longcope C, Baker S (1993) Androgen and estrogen dynamics: relationship with age, weight, and menopausal status. J Clin Endocrinol Metab 76:601–210PubMedCrossRefGoogle Scholar
  81. 81.
    Meldrum DR, Davidson BJ, Tatryn IV, Judd HL (1981) Changes in circulating steroids with aging in postmenopausal women. Obstet Gynecol 57:624–628PubMedGoogle Scholar
  82. 82.
    Longcope C, Johnston CC Jr (1990) Androgen and estrogen dynamics: stability over a two year interval in perimenopausal women. J Steroid Biochem 35(1):91–95PubMedCrossRefGoogle Scholar
  83. 83.
    Adashi EY (1994) The climacteric ovary as a functional gonadotropin-driven androgen-­producing gland. Fertil Steril 62:20–27PubMedGoogle Scholar
  84. 84.
    Ushiroyama T, Sugimoto O (1995) Endocrine function of the peri- and postmenopausal ovary. Horm Res 44:64–68PubMedCrossRefGoogle Scholar
  85. 85.
    Puluso JJ, Steger RW, Jaszezak S, Hafez ES (1976) Gonadotropin binding sites in human postmenopausal ovaries. Fertil Steril 27:789–795Google Scholar
  86. 86.
    Nakano R, Shima K, Yamoto M, Kobayashi M, Nishimori K, Hiraoka J (1989) Binding sites for gonadotropins in human postmenopausal ovaries. Obstet Gynecol 73:196–200PubMedGoogle Scholar
  87. 87.
    Dennefors BL, Janson PO, Hamberger L, Knutsson F (1982) Hilus cells from human postmenopausal ovaries: gonadotrophin sensitivity, steroid and cyclic AMP production. Acta Obstet Gynecol Scand 61:413–416PubMedCrossRefGoogle Scholar
  88. 88.
    Dowsett M, Cantwell B, Lal A, Jeffcoate SL, Harris AL (1988) Suppression of postmenopausal ovarian steroidogenesis with the luteinizing hormone-releasing hormone agonist goserelin. J Clin Endocrinol Metab 66:672–677PubMedCrossRefGoogle Scholar
  89. 89.
    Nagamani M, Urban RJ (2003) Expression of messenger ribonucleic acid encoding steroidogenic enzymes in postmenopausal ovaries. J Soc Gynecol Invest 10:37–40CrossRefGoogle Scholar
  90. 90.
    Couzinet B, Meduri G, Leece MG, Young J, Brailly S, Loosfelt H, Milgrom E, Schaison G (2001) The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86:5060–5066PubMedCrossRefGoogle Scholar
  91. 91.
    Jabara S, Christenson LK, Wang CY, McAllister JM, Javitt NB, Dunaif A, Strauss JF III (2003) Stromal cells of the human postmenopausal ovary display a distinctive biochemical and molecular phenotype. J Clin Endocrinol Metab 88:484–492PubMedCrossRefGoogle Scholar
  92. 92.
    Havelock JC, Rainey WE, Bradshaw KD, Carr BR (2006) The post-menopausal ovary displays a unique pattern of steroidogenic enzyme expression. Hum Reprod 21(1):309–317PubMedCrossRefGoogle Scholar
  93. 93.
    Melton J, Khosla S, Malkasian G, Achenbach S, Oberg A, Riggs L (2003) Fracture risk after bilateral oophorectomy in elderly women. J Bone Miner Res 18:900–905PubMedCrossRefGoogle Scholar
  94. 94.
    Writing Group for the WHI Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women’s Health Initiative Randomized Controlled Trial. JAMA 288:321–333CrossRefGoogle Scholar
  95. 95.
    Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML (2007) Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297(13):1465–1477PubMedCrossRefGoogle Scholar
  96. 96.
    Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R (2006) Conjugated equine estrogens and coronary heart disease: the Women’s Health Initiative. Arch Intern Med 166:357–365PubMedCrossRefGoogle Scholar
  97. 97.
    Manson JE, Allison MA, Rossouw JE, Carr JJ, Langer RD, Hsia J, Kuller LH, Cochrane BB, Hunt JR, Ludlam SE, Pettinger MB, Gass M, Margolis KL, Nathan L, Ockene JK, Prentice RL, Robbins J, Stefanick ML; for the WHI and WHI-CACS Investigators (2007) Estrogen therapy and coronary-artery calcification. N Engl J Med 356(25):2591–2602CrossRefGoogle Scholar
  98. 98.
    Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA (2002) Hysterectomy surveillance – United States, 1994–1999. MMWR Surveill Summ 51(SS05):1–8Google Scholar

Copyright information

© Humana Press 2010

Authors and Affiliations

  1. 1.Department of Obstetrics & GynecologyStanford University Hospital and ClinicsStanfordUSA

Personalised recommendations